Evolus (EOLS)
(Delayed Data from NSDQ)
$9.15 USD
+0.23 (2.58%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.15 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EOLS 9.15 +0.23(2.58%)
Will EOLS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EOLS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EOLS
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for
Earnings Preview: Evolus, Inc. (EOLS) Q2 Earnings Expected to Decline
EOLS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Evolus, Inc. (EOLS) Reports Q1 Loss, Misses Revenue Estimates
SNDL Inc. (SNDL) Reports Q1 Loss, Misses Revenue Estimates
Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know
Other News for EOLS
Evolus to Report Second Quarter Financial Results on August 5, 2025 | EOLS Stock News
Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | EOLS Stock News
EOLS Partners with Symatese for Nuceiva Distribution in France | EOLS Stock News